Next Generation News and Research

RSS

UH Case Medical Center, ABL partner to design and validate HIV drug resistance tests

University Hospitals Case Medical Center has signed an agreement with Advanced Biological Laboratories, an information technology and diagnostic company based in Luxembourg, to join efforts on the designing and validation of an HIV drug resistance and tropism assay based on next-generation sequencing (NGS).

14 Jan 2015

Sophia Genetics obtains CE-IVD marking for BRCA1/2 testing solution

Sophia Genetics, the European leader in Data Driven Medicine, has today obtained CE-IVD marking for its solution to detect BRCA1/2 associated genetic variants in live tumours.

14 Jan 2015

Doximity names UC San Diego School of Medicine among nation's top residency training programs

UC San Diego School of Medicine was today named one of the nation's top residency training programs in 10 specialties by Doximity. The Doximity report included more than 50,000 peer nominations from board-certified US physicians, and evaluated 3,691 residency training programs across 20 specialties.

14 Jan 2015

Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Intrexon Corporation, a leader in synthetic biology and its oncology partner, ZIOPHARM Oncology, today announced a broad exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sublicensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies.

14 Jan 2015

Valorem Surgical reports FDA approval and first utilization of MaxiMIS Spinal Fixation System

Valorem Surgical, an early stage medical device company with a platform on surgically treating spinal pathologies through a minimally invasive (MIS) approach, today announced that the Company has received FDA clearance and its first case utilizing its minimally invasive MaxiMIS Spinal Fixation System, performed by board-certified, neurosurgeon, Dr. Jae Lim in Reston, VA.

13 Jan 2015

HealthLoop releases new doctor-patient engagement app

HealthLoop released a new app of its doctor-patient engagement platform today. HealthLoop+ MD is another step forward in bringing the latest technology and innovation of next generation follow-up care to doctors and patients.

13 Jan 2015

Beckman Coulter Genomics announces CAP accreditation

Beckman Coulter Genomics, a leading provider of DNA Sequencing Services announces today accreditation from the College of American Pathologists (CAP).

From Beckman Coulter Life Sciences - Automation and Genomics 13 Jan 2015

EGFR mutations, ALK translocations not mutually exclusive in NSCLC

Researchers from the Republic of Korea have found that epidermal growth factor receptor mutations and anaplastic lymphoma kinase translocations can occur concomitantly in a proportion of patients with non-small-cell lung cancer.

12 Jan 2015

Blast phase characteristics differ in TKI-, non-TKI–treated CML patients

Features of the blast phase, such as blast cell morphology and accompanying cytogenetic changes, vary between chronic myeloid leukaemia patients who received tyrosine kinase inhibitor therapy and those treated in the pre-TKI era, research shows.

12 Jan 2015

HLI gains access to PGDx's cancer genomics solutions to expand cancer genome analysis

Personal Genome Diagnostics, Inc., a provider of advanced cancer genome analysis and testing services, and Human Longevity, Inc., the human health information technology and health care company, today announced that HLI will have access to PGDx's cancer genomics solutions to expand its analysis of cancer genomes, including CancerSelect, PlasmaSelect, CancerXome, METDetect and CancerComplete.

12 Jan 2015

ACS announces launch of new initiative to increase membership

Today the American College of Surgeons announced the launch of a new initiative aimed at stimulating more young surgeons (defined as under the age of 45) to become involved in the organization and increase membership.

8 Jan 2015

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014.

1 Jan 2015

Cardiac arrest associated with high mortality even in the world of Star Trek

The Star Trek universe is one of the most popular pieces of science fiction entertainment. Lots of the technologies seen in the TV and cinema episodes featuring Captain Kirk, Mr Spock or Captain Picard were once regarded as futuristic, but have now become reality - with examples including wireless communication or portable computers. In a recent study by the University Department of Emergency Medicine at the MedUni Vienna, the make-believe future of the human race depicted in this series has been used to investigate the frequency and mortality of cardiac arrests in the 24th century.

1 Jan 2015

Next generation sequencing in malignant pleural mesothelioma tumors reveals complex mutational setting

Next generation sequencing in malignant pleural mesothelioma (MPM) tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell survival and cell proliferation pathways. Increased accumulation of mutations correlates with early progression of the tumor and decreased survival.

23 Dec 2014

Offspring of mice treated with drug had delayed onset, reduced symptoms of Huntington's disease

Famine, drug abuse and even stress can "silence" certain genes, causing health problems in generations to come. Now scientists are wondering—could therapies that change gene expression in parents help their children?

23 Dec 2014

Roche announces acquisition of Bina Technologies

Roche announced today the acquisition of Bina Technologies, Inc., a privately held company based in Redwood City, California, USA. Bina provides a big data platform for centralized management and processing of next generation sequencing (NGS) data.

19 Dec 2014

UTSA, UTHSCSA researchers to jointly develop next-generation breast cancer treatment drugs

Stanton McHardy, associate professor of chemistry and director of the Center for Innovative Drug Discovery in The University of Texas at San Antonio College of Sciences, is partnering on a $1.9 million award to develop next-generation breast cancer treatment drugs.

19 Dec 2014

Secrets of success for pioneering research revealed

The British Pharmacological Society has announced the secrets of success for pioneering research along with the outcome of its annual 'Putting UK Pharmacology on the Map' vote. The vote selects sites of special scientific interest linked to achievements in pharmacology based on a ballot of MPs, peers and senior members of the scientific community.

18 Dec 2014

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Penumbra, Inc., the market leader in intra-arterial stroke treatment, announced that an independent study published online today in the New England Journal of Medicine found that intra-arterial stroke treatment, including the company's clot extraction technology, was shown to be significantly more effective than medical management with tissue plasminogen activator (tPA), which is the current standard of care.

18 Dec 2014

Scientists demonstrate technique for editing genome in sperm-producing adult stem cells

Scientists at Indiana University and colleagues at Stanford and the University of Texas have demonstrated a technique for "editing" the genome in sperm-producing adult stem cells, a result with powerful potential for basic research and for gene therapy.

16 Dec 2014

Next Generation News and Research

UH Case Medical Center, ABL partner to design and validate HIV drug resistance tests

Sophia Genetics obtains CE-IVD marking for BRCA1/2 testing solution

Doximity names UC San Diego School of Medicine among nation's top residency training programs

Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Valorem Surgical reports FDA approval and first utilization of MaxiMIS Spinal Fixation System

HealthLoop releases new doctor-patient engagement app

Beckman Coulter Genomics announces CAP accreditation

EGFR mutations, ALK translocations not mutually exclusive in NSCLC

Blast phase characteristics differ in TKI-, non-TKI–treated CML patients

HLI gains access to PGDx's cancer genomics solutions to expand cancer genome analysis

ACS announces launch of new initiative to increase membership

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Cardiac arrest associated with high mortality even in the world of Star Trek

Next generation sequencing in malignant pleural mesothelioma tumors reveals complex mutational setting

Offspring of mice treated with drug had delayed onset, reduced symptoms of Huntington's disease

Roche announces acquisition of Bina Technologies

UTSA, UTHSCSA researchers to jointly develop next-generation breast cancer treatment drugs

Secrets of success for pioneering research revealed

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Scientists demonstrate technique for editing genome in sperm-producing adult stem cells

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News